4.7 Article

COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria

Journal

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 106, Issue -, Pages 29-32

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2021.03.071

Keywords

COVID-19; Malaria; TB; HIV; Impact; Challenges

Funding

  1. Federal Ministry of Education and Research, Germany [BMBF-01KI2052]
  2. European and Developing Countries Clinical Trials Partnership (EDCTP) Central African Network for Tuberculosis, HIV/AIDS and malaria (CANTAM) [EDCTP-RegNet 2015-1045]
  3. Pan African Network for Rapid Research, Response, and Preparedness for Infectious Diseases Epidemics Consortium (PANDORA-ID-NET) [EDCTP-RIA2016E-1609]

Ask authors/readers for more resources

The indirect effects of the COVID-19 pandemic have the potential to seriously undermine the health system in sub-Saharan Africa, leading to an increase in the incidences of malaria, tuberculosis (TB) and HIV infections. Based on current evidence in the African region, the collateral impact of COVID-19 on the big three diseases shall be addressed.
Indirect effects of the COVID-19 pandemic have the potential to seriously undermine the health system in sub-Saharan Africa with an increase in the incidences of malaria, tuberculosis (TB) and HIV infections. Based on current evidence in the African region the collateral impact of COVID-19 on the big three diseases shall be addressed in the following. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available